We investigated the use of a system with an ingestible sensor (Proteus Digital Health
Feedback system) coencapsulated with antiretrovirals (ARVs) to measure real-time …

Summary Background Co-encapsulated antiretrovirals (ARVs) with ingestible sensor (IS)
has the capacity to monitor adherence in real-time using a sensor patch, a mobile device …

Adherence to tenofovir disoproxil fumarate/emtricitabine (TDF/FTC, Truvada®) is the primary
determinant of HIV pre-exposure prophylaxis (PrEP) efficacy. Despite its importance …

Adherence with antiretroviral therapy is important for preventing disease progression and
HIV transmission. The co‐encapsulated pill sensor system sends a signal through a …

Abstract Purpose of Review This review summarizes the recent advancements and future
directions of digital pill systems (DPS)—which utilize ingestible sensors to directly measure …

Digital pills, gelatin capsules with radiofrequency transmitters activated by stomach chloride
ions, directly measure antiretroviral therapy adherence. In individuals with substance use …

Background: Virological failure during antiretroviral treatment (ART) may indicate the
presence of drug resistance, but may also originate from nonadherence. Qualitative …

Once daily tenofovir/emtricitabine when used for pre-exposure prophylaxis (PrEP) is
effective in preventing HIV acquisition but requires consistent medication adherence. The …

In a recently published paper, Rowe and colleagues1 describe a case of an acutely
hospitalized cisgender male recently diagnosed as a person living with HIV (PWH) who did …

Poor adherence to pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) can
lead to human immunodeficiency virus (HIV) acquisition and emergence of drug-resistant …